A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease

计划入组 131 人 · 首次发布于 2005 年 12 月 14 日

A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis

计划入组 249 人 · 首次发布于 2005 年 9 月 21 日

IL-6, IL-12, IL-15 and IL-23 Expression Levels in Rheumatoid Arthritis Patients

计划入组 80 人 · 首次发布于 2024 年 8 月 16 日

TACI X IL-12p40 antibody fusion protein(Jiangsu Hengrui Pharmaceuticals)

IL-25

IL-233

Simcha Il 18, Inc.

United States

Alliance Foundation Trials, LLC

United States

UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA

Italy

Montai Therapeutics Advances First-in-Class Oral NRF2 Agonist for Ulcerative Colitis to IND-Enabling Studies

Landmark Clinical Trials Demonstrate Efficacy of IL-13 and IL-4/IL-13 Inhibitors in Patients with Darker Skin Tones

Medicenna Secures Five New Patents for IL-2 and IL-4 Superkine Immunotherapies